CRISPLD1: a novel conserved target in the transition to human heart failure
Standard
CRISPLD1: a novel conserved target in the transition to human heart failure. / Khadjeh, Sara; Hindmarsh, Vanessa; Weber, Frederike; Cyganek, Lukas; Vidal, Ramon O; Torkieh, Setare; Streckfuss-Bömeke, Katrin; Lbik, Dawid; Tiburcy, Malte; Mohamed, Belal A; Bonn, Stefan; Toischer, Karl; Hasenfuss, Gerd.
in: BASIC RES CARDIOL, Jahrgang 115, Nr. 3, 07.03.2020, S. 27.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - CRISPLD1: a novel conserved target in the transition to human heart failure
AU - Khadjeh, Sara
AU - Hindmarsh, Vanessa
AU - Weber, Frederike
AU - Cyganek, Lukas
AU - Vidal, Ramon O
AU - Torkieh, Setare
AU - Streckfuss-Bömeke, Katrin
AU - Lbik, Dawid
AU - Tiburcy, Malte
AU - Mohamed, Belal A
AU - Bonn, Stefan
AU - Toischer, Karl
AU - Hasenfuss, Gerd
PY - 2020/3/7
Y1 - 2020/3/7
N2 - Heart failure is a major health problem worldwide with a significant morbidity and mortality rate. Although studied extensively in animal models, data from patients at the compensated disease stage are lacking. We sampled myocardium biopsies from aortic stenosis patients with compensated hypertrophy and moderate heart failure and used transcriptomics to study the transition to failure. Sequencing and comparative analysis of analogous samples of mice with transverse aortic constriction identified 25 candidate genes with similar regulation in response to pressure overload, reflecting highly conserved molecular processes. The gene cysteine-rich secretory protein LCCL domain containing 1 (CRISPLD1) is upregulated in the transition to failure in human and mouse and its function is unknown. Homology to ion channel regulatory toxins suggests a role in Ca2+ cycling. CRISPR/Cas9-mediated loss-of-function leads to dysregulated Ca2+ handling in human-induced pluripotent stem cell-derived cardiomyocytes. The downregulation of prohypertrophic, proapoptotic and Ca2+-signaling pathways upon CRISPLD1-KO and its upregulation in the transition to failure implicates a contribution to adverse remodeling. These findings provide new pathophysiological data on Ca2+ regulation in the transition to failure and novel candidate genes with promising potential for therapeutic interventions.
AB - Heart failure is a major health problem worldwide with a significant morbidity and mortality rate. Although studied extensively in animal models, data from patients at the compensated disease stage are lacking. We sampled myocardium biopsies from aortic stenosis patients with compensated hypertrophy and moderate heart failure and used transcriptomics to study the transition to failure. Sequencing and comparative analysis of analogous samples of mice with transverse aortic constriction identified 25 candidate genes with similar regulation in response to pressure overload, reflecting highly conserved molecular processes. The gene cysteine-rich secretory protein LCCL domain containing 1 (CRISPLD1) is upregulated in the transition to failure in human and mouse and its function is unknown. Homology to ion channel regulatory toxins suggests a role in Ca2+ cycling. CRISPR/Cas9-mediated loss-of-function leads to dysregulated Ca2+ handling in human-induced pluripotent stem cell-derived cardiomyocytes. The downregulation of prohypertrophic, proapoptotic and Ca2+-signaling pathways upon CRISPLD1-KO and its upregulation in the transition to failure implicates a contribution to adverse remodeling. These findings provide new pathophysiological data on Ca2+ regulation in the transition to failure and novel candidate genes with promising potential for therapeutic interventions.
KW - Amino Acid Sequence
KW - Animals
KW - Aortic Valve Stenosis/complications
KW - Apoptosis
KW - Biopsy
KW - Calcium/metabolism
KW - Calcium Signaling
KW - Cell Adhesion Molecules/chemistry
KW - Conserved Sequence
KW - Down-Regulation
KW - Evolution, Molecular
KW - Female
KW - Heart Failure/complications
KW - Humans
KW - Induced Pluripotent Stem Cells/cytology
KW - Male
KW - Mice
KW - Myocardium/metabolism
KW - Myocytes, Cardiac/cytology
KW - Transcriptome
KW - Transforming Growth Factor beta/metabolism
U2 - 10.1007/s00395-020-0784-4
DO - 10.1007/s00395-020-0784-4
M3 - SCORING: Journal article
C2 - 32146539
VL - 115
SP - 27
JO - BASIC RES CARDIOL
JF - BASIC RES CARDIOL
SN - 0300-8428
IS - 3
ER -